Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
7.23
-0.29 (-3.86%)
Nov 16, 2026, 4:00 PM EST - Market closed

Immunic Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
131.9615.4835.6746.67106.7586.86
Short-Term Investments
----9.63-
Cash & Short-Term Investments
131.9615.4835.6746.67116.3786.86
Cash Growth
275.62%-56.59%-23.58%-59.89%33.97%-31.85%
Other Receivables
-4.120.682.482.662.15
Receivables
-4.120.682.482.662.15
Prepaid Expenses
-2.061.872.315.6115.98
Other Current Assets
3.121.21.111.071.23-
Total Current Assets
135.0922.8739.3352.53125.86104.99
Property, Plant & Equipment
1.341.181.541.771.851.1
Goodwill
-----32.97
Other Long-Term Assets
----0.040.04
Total Assets
136.4224.0540.8754.3127.75139.1

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
10.1210.147.855.14.283.75
Accrued Expenses
20.0618.6512.9118.667.997.07
Current Portion of Leases
-0.470.740.70.570.41
Other Current Liabilities
1.371.370.680.270.240.18
Total Current Liabilities
31.5530.6222.1824.7313.0811.4
Long-Term Leases
-0.110.260.640.990.58
Total Liabilities
31.9530.7322.4425.3714.0711.99

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
00.010.01000
Additional Paid-In Capital
819.29599.24525.61436.06427.93324.24
Retained Earnings
-717.57-608.57-511.4-410.89-317.28-196.87
Comprehensive Income & Other
2.752.654.213.763.04-0.25
Total Common Equity
104.47-6.6718.4328.93113.68127.12
Shareholders' Equity
104.47-6.6718.4328.93113.68127.12
Total Liabilities & Equity
136.4224.0540.8754.3127.75139.1

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
-0.5811.331.560.99
Net Cash (Debt)
131.9614.9134.6645.34114.8185.87
Net Cash Growth
284.28%-57.00%-23.55%-60.51%33.70%-32.10%
Net Cash Per Share
3.910.963.4610.2336.0836.30
Filing Date Shares Outstanding
15.8813.059.028.994.442.79
Total Common Shares Outstanding
15.8812.049.024.523.932.63
Working Capital
103.54-7.7517.1627.81112.7993.59
Book Value Per Share
6.58-0.552.046.4028.9248.27
Tangible Book Value
104.47-6.6718.4328.93113.6894.15
Tangible Book Value Per Share
6.58-0.552.046.4028.9235.75
SEC Filings: 10-K · 10-Q